Patents by Inventor Seigo Takasawa
Seigo Takasawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5316767Abstract: Disclosed is a whitening cosmetic composition comprising .gamma.-L-glutamyl-L-cystine, .gamma.-L-glutamyl-L-cysteine disulfide, oxidized glutathione or a derivative thereof, the amino group of which is acylated with an alkanoyl group or an aroyl group. The whitening cosmetic composition of the present invention have extremely good in water solubility and heat stability and stability during storage and show a melanin formation inhibitory activity against melanoma cells without any cytotoxicity.Type: GrantFiled: December 3, 1992Date of Patent: May 31, 1994Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Takahiro Hara, Seigo Takasawa, Yoshiharu Yokoo, Tadayasu Furukawa
-
Patent number: 4734494Abstract: Optically active cephalosporin analogs are produced by optically selective deacylation of an optically inactive acylated analog. The compounds are useful as intermediates in the preparation of optically active acylated antimicrobial agents.Type: GrantFiled: November 6, 1986Date of Patent: March 29, 1988Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Tadashi Hirata, Yukio Hashimoto, Ikuo Matsukuma, Shigeo Yoshiie, Seigo Takasawa
-
Patent number: 4663450Abstract: Optically active cephalosporin analogs of the formula ##STR1## wherein R.sub.2 represents a hydrogen or a group represented by the formula ##STR2## wherein R.sub.3 is a straight or branched lower alkyl group having 1 to 6 carbon atoms, a straight or branched lower alkoxy group having 1 to 6 carbon atoms or a phenyl group and R.sub.4 is a hydrogen or a straight or branched lower alkyl group having 1 to 6 carbon atoms; and A.sub.2 represents a straight or branched lower alkyl group having 1 to 6 carbon atoms or a straight or branched lower alkyl group having 1 to 6 carbon atoms which is substituted with one or two carboxyl groups, are useful as antibacterial agents.Type: GrantFiled: October 17, 1985Date of Patent: May 5, 1987Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Tadashi Hirata, Yukio Hashimoto, Takehiro Ogasa, Shigeru Kobayashi, Akira Sato, Kiyoshi Sato, Seigo Takasawa
-
Patent number: 4634670Abstract: Cellulase may be prepared in good yield and at relatively low cost by culturing certain mutant strains of the genus Trichoderma, which exhibit increased inducibility of cellulase by L-sorbose, in medium wherein the carbon source comprises cellulose-containing material of plant origin, for example, bagasses, waste papers, rice plant hulls and straws or soybean wastes. Preferred mutant strains are exemplified by Trichoderma reesei PC-1-4, PC-3-7, X-30 and X-31.Type: GrantFiled: July 27, 1984Date of Patent: January 6, 1987Assignee: Shin Nenryoyu Kaihatsu Gijutsu Kenkyu KumiaiInventors: Seigo Takasawa, Yasushi Morikawa
-
Patent number: 4623722Abstract: New antibiotic compounds, Fortimicin factors KG.sub.1, KG.sub.2 and KG.sub.3 are produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom.Type: GrantFiled: February 11, 1980Date of Patent: November 18, 1986Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Seigo Takasawa, Kunikatsu Shirahata, Seiji Sato, Keiichi Takahashi
-
Patent number: 4472501Abstract: Ethanol is produced by culturing the microorganism Kluyveromyces cellobiovorus or Kloeckera apiculata in a medium containing, as a carbon source, an assimilable source of xylose, cellobiose or both. The carbon source may be provided in the form of hydrolysates of cellulose containing substances such as cotton, wood, straw or paper which are obtained by acid hydrolysis or enzymatic action. At the completion of culturing, ethanol is removed from the culture in a conventional manner.Type: GrantFiled: August 10, 1982Date of Patent: September 18, 1984Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Seigo Takasawa, Yasushi Morikawa, Kenichiro Takayama, Izumi Masunaga
-
Patent number: 4335211Abstract: Disclosed are optically active acylated cephalosporin analogs which are useful as antibacterial agents and methods for preparing such compounds.Type: GrantFiled: November 13, 1980Date of Patent: June 15, 1982Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Yukio Hashimoto, Seigo Takasawa, Tadashi Hirata, Ikuo Matsukuma, Shigeo Yoshiie
-
Patent number: 4302541Abstract: Optically active cephalosporin analogs are produced by optically selective deacylation of an optically inactive acylated analog. The compounds are useful as intermediates in the preparation of optically active acylated antimicrobial agents.Type: GrantFiled: November 13, 1980Date of Patent: November 24, 1981Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Tadashi Hirata, Yukio Hashimoto, Ikuo Matsukuma, Shigeo Yoshiie, Seigo Takasawa
-
Patent number: 4302540Abstract: Disclosed are optically active cephalosporin analogs which are produced by optically selective deacylation of an optically inactive acylated analog. The compounds are useful as intermediates in the preparation of optically active acylated antimicrobial agents.Type: GrantFiled: October 24, 1980Date of Patent: November 24, 1981Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Tadashi Hirata, Yukio Hashimoto, Takehiro Ogasa, Shigeru Kobayashi, Akira Sato, Kiyoshi Sato, Seigo Takasawa
-
Patent number: 4241182Abstract: New antibiotic compounds, Fortimicin factors KG.sub.1, KG.sub.2 and KG.sub.3 are produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom.Type: GrantFiled: March 5, 1979Date of Patent: December 23, 1980Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Seigo Takasawa, Kunikatsu Shirahata, Seiji Sato, Keiichi Takahashi
-
Patent number: 4045298Abstract: The antibiotic XK-62-2 is produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic is accumulated in the culture liquor and is isolated therefrom.Type: GrantFiled: June 15, 1976Date of Patent: August 30, 1977Assignee: Abbott LaboratoriesInventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato, Atsuko Morikawa
-
Patent number: 4045610Abstract: A novel series of antibiotics designated the XK-88 series are produced by culturing a microorganism belonging to the genus Streptomyces in a nutrient medium and thereafter recovering the antibiotics from the culture liquor.Type: GrantFiled: October 17, 1975Date of Patent: August 30, 1977Assignee: Abbott LaboratoriesInventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato, Atsuko Morikawa
-
Patent number: 3976768Abstract: A new antibiotic, Fortimicin A, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.Type: GrantFiled: July 22, 1974Date of Patent: August 24, 1976Assignee: Abbott LaboratoriesInventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato
-
Patent number: 3939043Abstract: A novel series of antibiotics designated the XK-88 series are produced by culturing a microorganism belonging to the genus Streptomyces in a nutrient medium and thereafter recovering the antibiotics from the culture liquor.BACKGROUND OF THE INVENTIONThe present invention relatees to novel antibiotics and a process for the production thereof. More specifically the present invention relates to novel antibiotics designated, XK-88-1, XK-88-2, XK-88-3 and XK-88-5 and a process for producing such antibiotics.Antibiotics which exhibit activity against a borad spectrum of bacteria are always in demand. To this end, a new species of microorganism has been isolated from soil located in Tajima-cho, Hofu-shi, Yamaguchi-ken, Japan. This new species, when cultured, produces a series of new antibiotics, the XK-88 series, all of which exhibit strong antibacterial activity against various Gram-positive and Gram-negative bacteria.Type: GrantFiled: October 21, 1974Date of Patent: February 17, 1976Assignee: Abbott LaboratoriesInventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato, Atsuko Morikawa
-
Patent number: 3931400Abstract: A new antibiotic, Fortimicin B, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.Type: GrantFiled: April 5, 1974Date of Patent: January 6, 1976Assignee: Abbott LaboratoriesInventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto